FDA Approved: BREZTRI — Original Application (AstraZeneca Pharmaceuticals LP)

View source ↗

Summary

FDA granted original approval for BREZTRI, a triple inhaled therapy (budesonide/glycopyrrolate/formoterol fumarate) from AstraZeneca for the treatment of chroni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Breztri (budesonide/glycopyrronium/formoterol)

Snippet

ORIG AP for BREZTRI (BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE)